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The results of the study by Schottelius 
et al. (2010) raise the question of whether 
tissue-specific differences in immune 
responses are common in other cell sig-
naling pathways and how they might 
affect the inflammatory response. Their 
report highlights the importance of study-
ing the immune response in several mod-
els of tissue-specific inflammation before 
concluding that a specific cellular signal-
ing factor has pro- or anti-inflammatory 
effects. Most interestingly, the results 
could open new avenues for treating 
specific tissues locally with signaling 
factor antagonists and agonists. Such an 
approach could provide more favorable 
efficacy to side-effect ratios in treating 
tissue-specific inflammatory disorders.
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Genetic Influences on Human Body 
Odor: From Genes to the Axillae
George Preti1,2 and James J. Leyden2
several groups have identified the characteristic axillary odorants and how they 
arrive on the skin surface, pre-formed, bound to water-soluble odorless precur-
sors in apocrine secretions. In the current issue, Martin et al., (2010) describe 
the relationship between the production of axillary odorants and variants in 
the ABCC11 gene. Individuals who are homozygotic for a sNP (538G>A) were 
found to have significantly less of the characteristic axillary odorants than either 
individuals who were heterozygotic for this change or those who had the wild-
type gene. The 538G>A sNP predominates in Asians who have nearly complete 
loss of typical body odor. ABCC11 is expressed and localized in apocrine sweat 
glands. These findings are remarkably similar to the ethnic distribution and 
expression patterns for apocrine apoD, a previously identified carrier of a char-
acteristic axillary odorant.
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Human axillary odor (commonly 
referred to as “body odor”) is caused by 
a complex mixture of volatile organic 
compounds that produce a characteris-
tic odor that has been termed “uniquely 
human” (Labows et al., 1982). The nature 
and biogenesis of the odorants that con-
stitute the axillary bouquet are the focus 
of a multibillion-dollar industry that seeks 
new products to counteract odor produc-
tion and perception. In addition, axillary 
secretions and odors contain human 
primer pheromones that affect neuroen-
docrine rhythms, as well as modulator 
pheromones that can affect mood (Preti 
et al., 2003; also see Wysocki and Preti, 
2009, for a review).
Research into the nature of body odor 
began in the 1960s with the discovery 
that axillary odor could be produced 
by the interaction of odorless apocrine 
secretions (collected by injecting dilute 
epinephrine into the axilla after degerm-
ing the skin surface with alcohol) with 
inoculation by gram-positive organisms 
found on the skin surface (Shehadeh 
and Kligman, 1963a,b). Subsequent 
studies led by David Gower demon-
strated the presence of volatile, odorous 
C19-∆16 steroids—5α-androst-16-en-3β-
ol (androstenol) and 5α-androst-16-en-
3-one (androstenone)—in the axillae. 
These compounds were identified and 
quantified by radioimmunoassay and 
gas chromatography–mass spectrom-
etry techniques (see Rennie et al., 1991, 
and Gower and Ruparelia, 1993, for 
reviews). The urine/musk-like odors of 
these compounds were thought by these 
investigators and others (Labows et al., 
1979, 1982) to be suggestive of axillary 
odor. Research from our laboratory (Zeng 
et al., 1991, 1992, 1996a,b) as well as 
from Natsch et al. (2003) subsequently 
presented both organoleptic and ana-
lytical evidence that a mixture of C6–C11 
normal, branched, hydroxy- and unsatu-
rated acids present in axillary sweat 
commentary
 www.jidonline.org 345
constitute the dominant, characteristic 
axillary odors. In addition to this mix-
ture of major odor constituents are trace 
amounts of thio-alcohols (Natsch et al., 
2004; Troccaz et al., 2004; Hasegawa 
et al., 2004) with high odor impact (low 
olfactory threshold).
The precursors to axillary odor reside 
in the apocrine glands (Shehadeh and 
Kligman, 1963a,b; Zeng et al., 1992). 
The characteristic axillary odor is formed 
by the interaction of odorless, precursor 
molecules found in apocrine secretions 
with cutaneous, axillary microorgan-
isms (Shehadeh and Kligman, 1963a; 
Leyden et al., 1981; Zeng et al., 1991). 
In addition, Zeng et al. (1992) demon-
strated that the water-soluble portion of 
apocrine secretions contains the odor 
precursors and that one of the major 
axillary odorants, 3-methyl-2-hexenoic 
acid (3M2H), is carried to the skin sur-
face bound to two proteins that have 
been designated apocrine secretion 
odor-binding proteins: ASOB1 (appar-
ent molecular weight, 45 kDa) and 
ASOB2 (apparent molecular weight, 26 
kDa) (Spielman et al., 1995). Additional 
research documented that the polypep-
tide chain of ASOB2 is identical to that of 
apolipoprotein D (Zeng et al., 1996b), a 
known member of the α2µ-microglobulin 
superfamily of carrier proteins (also 
known as lipocalins) that carry lipids in 
the circulatory system (Flower, 1996). In 
apocrine secretions, apolipoprotein D 
(apoD) carries 3M2H, as demonstrated 
by Spielman et al. (1995) and Zeng et 
al. (1996a). Spielman et al. (1998) also 
demonstrated that axillary biopsies 
taken from both male and female volun-
teers exhibit specific immuno reactivity 
for apocrine apoD localized to the apo-
crine gland. Finally, Zeng et al. (1996a) 
employed in situ hybridization with an 
oligonucleotide probe against apoD 
mRNA using biopsied axillary tissue 
to demonstrate that the message for 
synthesis of this protein is specific to the 
apocrine glands.
In this issue, Martin et al. (2010) 
describe the relationship between 
the production of axillary odorants 
and variants in the ABCC11 gene. 
Individuals who were homozygotic for 
a single-nucleotide polymorphism (SNP) 
(538G>A) that changes amino acid 
180 in the resultant protein’s polypep-
tide chain from glycine (G) to arginine 
(R) were found to have a significantly 
smaller amount of the characteristic 
axillary odorants than either those who 
were heterozygotic for this change or 
those who had the wild-type gene. The 
ABCC11 gene encodes an ATP-driven 
efflux pump that plays an important 
function in ceruminous apocrine glands 
of the auditory canal. The 538G>A SNP 
is associated with a dry white earwax 
phenotype that is predominant in Asians 
and rare in Africans and Europeans. This 
same SNP predominates in Asians who 
have nearly complete loss of typical body 
odor. The ABCC11 protein is expressed 
and localized in apocrine sweat glands 
and appears to play a key role in the 
secretion and/or formation of glutamine 
precursors to axillary odorants.
When Jacoby et al. (2004) studied 
the levels of apocrine apoD in a group 
of subjects of different ethnic back-
grounds, they reported that subjects of 
Asian descent had diminished or non-
detectable levels of apoD in axillary 
skin extracts; in non-Asian subjects this 
protein was easily detected. These data 
are remarkably similar to those report-
ed here by Martin et al. (2010) for the 
ABCC11 gene and its expressed protein 
(human ABC transporter) and raise the 
question of whether a relationship exists 
between apoD and this protein.
The collection method employed 
by Martin et al. (2010) used exercise to 
collect mixed axillary sweat, yielding 
a combination of fluids from eccrine, 
apocrine, and apoeccrine glands, when 
present (Sato et al., 1987). The last are 
hybrid sweat glands that have been 
documented in the axillae of some indi-
viduals by Sato et al. (1987). The protein 
levels reported by Martin et al. (2010) for 
sweat from their strong odor producers 
(GG homozygotics; ~1 mg/ml) are lower 
than that reported for apocrine secre-
tions by Spielman et al. (1998; ~4.2 mg/
ml) and Jacoby et al. (2004; 45 mg/ml). 
This could indicate that substantial deg-
radation of proteins may have occurred 
in their samples. Interestingly, our stud-
ies with apocrine secretion (Zeng et al., 
1992; Spielman et al., 1995; Zeng et al., 
1996a,b), collected under sterile con-
ditions, reported no glutamine-bound 
precursors, suggesting that they may be 
formed in the initial interactions between 
cutaneous bacteria and protein-bound 
odorants. For example, apoD has pyro-
glutamate as its N-terminal amino acid, 
and Martin and colleagues’ collection 
method allows ample time for (i) open-
ing of the protein’s callix (making 3M2H 
and other acids carried within the pro-
tein available) and (ii) bacterial cleav-
age of the N-terminal pyroglutamate via 
bacterial N-acyl-aminocyclase enzyme 
(Natsch et al., 2003), which would liber-
ate glutamate for interaction with 3M2H 
and other acids, viz.
Martin et al. (2010) did not explore 
the discovery of apoD by Zeng et al. 
(1996b) or its quantification in axillary 
secretions by Jacoby et al. (2004) in rela-
tion to their findings. Consequently, the 
relationship between the two proteins, 
their expression in different ethnic 
groups, and their regulation of axillary 
odorant production constitute attractive 
areas for future study.
Pyroglutamate-
N-apoD
Bacterial 
N-acyl-aminocyclase
and other enzymes
3M2H + G1n + peptide fragments
3M2H−G1n + peptide fragments
+
Clinical Implications
•  Axillary odor is determined by variants in the ABCC11 gene, which 
encodes an ATP-driven efflux pump protein.
•  Individuals who are homozygotic for a SNP (538G>A) in the protein’s 
polypeptide chain have significantly less of the characteristic axillary 
odorants.
•  The 538G>A SNP predominates in Asians who have nearly complete loss 
of typical body odor.
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some Light on  
the Photobiology of Vitamin D
Antony R. Young1
In this issue, Bogh et al. report a study that begins to address the important public 
health question of skin surface area and UVB exposure dose, related to erythema, 
necessary to achieve a given level of vitamin D status. They demonstrate the impor-
tance of baseline vitamin D status in conducting such studies. A smaller substudy 
suggests that skin pigment is not a barrier to vitamin D photosynthesis.
Journal of Investigative Dermatology (2010) 130, 346–348. doi:10.1038/jid.2009.419
Introduction
The benefits of vitamin D and how best 
to obtain and maintain optimal lev-
els are highly controversial topics that 
have enormous potential implications 
for human health. Nature has provided 
humans with two sources of vitamin D: 
solar UVB radiation and diet. However, 
most foods provide very little vitamin D, 
especially in typical Western diets. The 
exception is oily fish. Manmade interven-
tions include food fortification in some 
countries, supplementation, and the use 
of tanning devices with UVB. Any discus-
sion on vitamin D status should be based 
on facts. There is a surprising lack of care-
ful, published investigation (as opposed 
to observation/extrapolation/calculation) 
into the photobiology of vitamin D in 
vivo and its interaction with skin color. 
Furthermore, there is a lack of data that 
compare the effects of UVR with other 
approaches to maintaining vitamin D 
status performed in the same laboratories 
to minimize experimental variation.
the significance of this study
The study by Bogh et al. (2010, this issue) 
is a welcome and timely addition to our 
knowledge in the photobiology field. 
The baseline data show that 85% of 
182 people screened for the study were 
either vitamin D (25(OH)D) insufficient 
(67% < 50 nmol l-1) or deficient (18% < 
25 nmol l-1) in Denmark at 56°N during 
the winter. The limitation of these defi-
nitions of vitamin D status is discussed 
in this issue’s Editorial, by Reddy and 
Gilchrest (2010). The backs and chests 
of volunteers with skin types I–VI were 
exposed to three standard erythema 
doses (SEDs) of UVB for 4 days over 
1 week. The UVB source used was very 
rich in the spectral region that converts 
7-dehydrocholesterol to pre–vitamin D 
in the skin. The sites exposed represent 
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